A Partneringdesk Deals Briefing provides an in-depth view of all the deals made by the company and its subsidiaries between 2001 and 2006, in a clear and accessible PDF format.Chapter 1: Company profi ...
Business Insight | 161 pages | September 2000 | English
In 1999, cardiovascular drugs represented the largest single segment of the global pharmaceutical industry by value. Estimated sales of $69.6bn represented growth of 8.2% over 1998 levels. ...
Global Industry Analyst | 128 pages | May 2008 | English
This report analyzes the worldwide markets for Insulin Pumps (External) in US$ Million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual forecas ...
IntroductionTropical diseases account for around 5 million deaths per year (WHO, 2002). Major contributors to these numbers are the mosquito borne diseases, which include West Nile Fever, Japanese ...
Business Insights have teamed up with IMS Health to bring you, The Antivirals Market Outlook: Market analysis of future growth and leading players by sector. This unique product offering provides an ...
IntroductionThe overall incidence of bladder cancer in the seven major markets is forecast to exceed 160,000 by the end of 2008. Treatment of bladder cancer employs mainly immunotherapy and chemoth ...
Plimsoll Publishing Ltd | 420 pages | February 2008 | English
The Plimsoll Portfolio Analysis - First Aid & Medical Supplies is a comprehensive evaluation of the UK market. The revised and updated 2008 edition analyses the financial performance of the compani ...
The purpose of this visiongain report is to examine the prospects for the growth of pharmaceutical revenues in the developing economies of Asia, Latin America and Eastern/Central Europe at both region ...
IntroductionDUSA Pharmaceuticals, a specialty dermatology pharmaceutical company, develops, manufactures, and markets the drug Levulan (5-aminolevulinic acid or ALA) for use in combination with light ...
Kalorama Information | 265 pages | December 2007 | English
As one of the most competitive pharmaceutical markets, keeping track of the cardiovascular drug market can be a difficult undertaking. The range of therapeutic options available to physicians has e ...